The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.

The standard of care in amyotrophic lateral sclerosis: a centralised multidisciplinary clinic encounter sets a new benchmark for a uniquely challenging neurodegenerative disorder.

Opis bibliograficzny
Główni autorzy:	Turner, M, Kiernan, M
Format:	Journal article
Język:	English
Wydane:	2014

Podobne zapisy

Biomarkers in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2009)

Amyotrophic lateral sclerosis.
od: Kiernan, M, i wsp.
Wydane: (2011)

Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
od: Turner, M, i wsp.
Wydane: (2012)

Familial neurodegenerative disease with parkinsonism syndrome and amyotrophic lateral sclerosis
od: T. K. Davydova, i wsp.
Wydane: (2018-11-01)

Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis
od: Kateřina Klíčová, i wsp.
Wydane: (2024-01-01)

Kinnier Wilson's puzzling features of amyotrophic lateral sclerosis
od: Turner, MR, i wsp.
Wydane: (2017)

Quantifying disease progression in amyotrophic lateral sclerosis.
od: Simon, N, i wsp.
Wydane: (2014)

Assessment of the upper motor neuron in amyotrophic lateral sclerosis
od: Huynh, W, i wsp.
Wydane: (2016)

The reunification of amyotrophic lateral sclerosis
od: Turner, M
Wydane: (2018)

Human cerebral evolution and the clinical syndrome of amyotrophic lateral sclerosis
od: Henderson, R, i wsp.
Wydane: (2018)

Clinicopathological features of primary lateral sclerosis are different from amyotrophic lateral sclerosis.
od: Hudson, A, i wsp.
Wydane: (1993)

Neuroimaging in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2012)

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations
od: Andrew Eisen, i wsp.
Wydane: (2025-02-01)

Controversies and priorities in amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2013)

Untangling neuroinflammation in amyotrophic lateral sclerosis
od: Thompson, AG, i wsp.
Wydane: (2019)

Regional callosal integrity and bilaterality of limb weakness in amyotrophic lateral sclerosis
od: Tu, S, i wsp.
Wydane: (2020)

Multidisciplinary care in amyotrophic lateral sclerosis: a 4-year longitudinal observational study
od: Eglė Sukockienė, i wsp.
Wydane: (2020-06-01)

Neuroimaging endpoints in amyotrophic lateral sclerosis
od: Menke, R, i wsp.
Wydane: (2016)

Occasional essay: Upper motor neuron syndrome in amyotrophic lateral sclerosis
od: Swash, M, i wsp.
Wydane: (2020)

Sweet food preference in amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2017)

Advances in the application of MRI to amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2010)

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
od: Turner, M
Wydane: (2011)

Defining pre-symptomatic amyotrophic lateral sclerosis
od: Benatar, M, i wsp.
Wydane: (2019)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
od: Bowser, R, i wsp.
Wydane: (2011)

Imaging cerebral activity in amyotrophic lateral sclerosis
od: Proudfoot, M, i wsp.
Wydane: (2019)

Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis
od: Tu, S, i wsp.
Wydane: (2018)

Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
od: Talbot, K, i wsp.
Wydane: (2006)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
od: Evans, M, i wsp.
Wydane: (2013)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis
od: Evans, M, i wsp.
Wydane: (2013)

Psychiatric disorders prior to amyotrophic lateral sclerosis
od: Turner, M, i wsp.
Wydane: (2016)

Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis
od: Turner, M
Wydane: (2018)

Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis.
od: Turner, M
Wydane: (2012)

The genetics of amyotrophic lateral sclerosis
od: Schymick, J
Wydane: (2009)

Complicated amyotrophic lateral sclerosis
od: Miguel González-Diaz, i wsp.
Wydane: (2024-01-01)

Myelin imaging in amyotrophic and primary lateral sclerosis.
od: Kolind, S, i wsp.
Wydane: (2013)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
od: Fabes, J, i wsp.
Wydane: (2017)

CSF chitinase proteins in amyotrophic lateral sclerosis
od: Thompson, A, i wsp.
Wydane: (2019)

Motor system biomarkers in amyotrophic lateral sclerosis
od: Edmond, EC, i wsp.
Wydane: (2019)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
od: Turner, M, i wsp.
Wydane: (2015)